Indeed, mTOR signaling interacts with TME through programmed cancer cell death axis (PD-L1/PD1) that is stimulated by PTEN deletion or loss of function [14,15], as well as effects on T cell differentiation [16,17]. Here, MTOR is linked to cancer.